Add Company
Join Now

Seal Rock Therapeutics Revenue and Competitors

License our Company Data API

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Seal Rock Therapeutics's estimated annual revenue is currently $1.4M per year.(i)
  • Seal Rock Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Seal Rock Therapeutics has 9 Employees.(i)
  • Seal Rock Therapeutics grew their employee count by 0% last year.

Seal Rock Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
SVP Business DevelopmentReveal Email/Phone
4
Director ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Seal Rock Therapeutics?

Seal Rock Therapeutics, Inc. is discovering and developing small molecule inhibitors of ASK1 (apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological and neurodegenerative indications.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.1M913%$42.7M
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$0.7M9N/AN/A